Drug information update. Lithium and chronic kidney disease: debates and dilemmas

Lithium is an established treatment for bipolar disorder and an augmenting agent for treatment-resistant depression. Despite awareness of renal adverse effects, including chronic kidney disease, for the past five decades, there has been a lack of research evidence. This has led to debates around the...

Descripción completa

Detalles Bibliográficos
Autores principales: Gupta, Sumeet, Khastgir, Udayan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Royal College of Psychiatrists 2017
Materias:
Special Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5537577/
https://www.ncbi.nlm.nih.gov/pubmed/28811917
http://dx.doi.org/10.1192/pb.bp.116.054031
_version_ 1783254210242936832
author Gupta, Sumeet
Khastgir, Udayan
author_facet Gupta, Sumeet
Khastgir, Udayan
author_sort Gupta, Sumeet
collection PubMed
description Lithium is an established treatment for bipolar disorder and an augmenting agent for treatment-resistant depression. Despite awareness of renal adverse effects, including chronic kidney disease, for the past five decades, there has been a lack of research evidence. This has led to debates around the existence and magnitude of the risk. This article discusses the current evidence base regarding the link between lithium and chronic kidney disease, monitoring of renal functions and its clinical implications.
format Online
Article
Text
id pubmed-5537577
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Royal College of Psychiatrists
record_format MEDLINE/PubMed
spelling pubmed-55375772017-08-15 Drug information update. Lithium and chronic kidney disease: debates and dilemmas Gupta, Sumeet Khastgir, Udayan BJPsych Bull Special Articles Lithium is an established treatment for bipolar disorder and an augmenting agent for treatment-resistant depression. Despite awareness of renal adverse effects, including chronic kidney disease, for the past five decades, there has been a lack of research evidence. This has led to debates around the existence and magnitude of the risk. This article discusses the current evidence base regarding the link between lithium and chronic kidney disease, monitoring of renal functions and its clinical implications. Royal College of Psychiatrists 2017-08 /pmc/articles/PMC5537577/ /pubmed/28811917 http://dx.doi.org/10.1192/pb.bp.116.054031 Text en © 2017 The Authors http://creativecommons.org/licenses/by/4.0 This is an open-access article published by the Royal College of Psychiatrists and distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Special Articles
Gupta, Sumeet
Khastgir, Udayan
Drug information update. Lithium and chronic kidney disease: debates and dilemmas
title Drug information update. Lithium and chronic kidney disease: debates and dilemmas
title_full Drug information update. Lithium and chronic kidney disease: debates and dilemmas
title_fullStr Drug information update. Lithium and chronic kidney disease: debates and dilemmas
title_full_unstemmed Drug information update. Lithium and chronic kidney disease: debates and dilemmas
title_short Drug information update. Lithium and chronic kidney disease: debates and dilemmas
title_sort drug information update. lithium and chronic kidney disease: debates and dilemmas
topic Special Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5537577/
https://www.ncbi.nlm.nih.gov/pubmed/28811917
http://dx.doi.org/10.1192/pb.bp.116.054031
work_keys_str_mv AT guptasumeet druginformationupdatelithiumandchronickidneydiseasedebatesanddilemmas
AT khastgirudayan druginformationupdatelithiumandchronickidneydiseasedebatesanddilemmas

Ejemplares similares